Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Near-Infrared-Activatable PROTAC Nanocages for Controllable Target Protein Degradation and On-Demand Antitumor Therapy
Qi He, Liming Zhou, D.P. Yu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10458-10472
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Nano-PROTACs: state of the art and perspectives
Jie Zhong, Ruiqi Zhao, Yuji Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4378-4391
Closed Access | Times Cited: 18
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Wan Su Yun, Soo Hyun Kim, Dong-Kwon Lim, et al.
Nanomaterials (2023) Vol. 13, Iss. 15, pp. 2225-2225
Open Access | Times Cited: 28
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
A PROTAC Augmenter for Photo‐Driven Pyroptosis in Breast Cancer
Daipeng Huang, Yang Zou, Haiqiao Huang, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 10
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 16
Designer Nanoreactors for Bioorthogonal Catalysis
Amit Kumar, In Su Lee
Accounts of Chemical Research (2024)
Closed Access | Times Cited: 5
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
Yu Chen, Fengyuan Liu, Samira Pal, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 19, pp. 9582-9608
Closed Access | Times Cited: 5
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 4
Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy
Chang-Hao Jiang, Yonghui Li, Yue Yuan, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains
Chuhui Huang, Claire L. Harris, Ghizal Siddiqui, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications
Narayanaperumal Pravin, Krzysztof Jóźwiak
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116837-116837
Open Access | Times Cited: 3
Recent Advances in Optically Controlled PROTAC
Muzi Ouyang, Ying Feng, Hui Chen, et al.
Bioengineering (2023) Vol. 10, Iss. 12, pp. 1368-1368
Open Access | Times Cited: 7
A photoactivatable upconverting nanodevice boosts the lysosomal escape of PROTAC degraders for enhanced combination therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 2
Discovery of an activatable near-infrared fluorescent and theranostic PROTAC for tumor-targeted detecting and degrading of BRD4
Keliang Li, Guoqiang Dong, Shanchao Wu, et al.
Chinese Chemical Letters (2024), pp. 110280-110280
Closed Access | Times Cited: 2
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
Versatile Split-and-Mix Liposome PROTAC Platform for Efficient Degradation of Target Protein In Vivo
Chunli Song, Zijun Jiao, Zhanfeng Hou, et al.
JACS Au (2024) Vol. 4, Iss. 8, pp. 2915-2924
Open Access | Times Cited: 1
Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed
Karim Kanbar, Roy El Darzi, Diana E. Jaalouk
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
BioTech (2023) Vol. 12, Iss. 3, pp. 57-57
Open Access | Times Cited: 3
Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
(2023)
Open Access | Times Cited: 2
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Angewandte Chemie (2024)
Closed Access
Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras
Mei-Yu Lv, Da‐Yong Hou, Shaowei Liu, et al.
ACS Nano (2024) Vol. 19, Iss. 1, pp. 101-119
Closed Access
Page 1 - Next Page

Scroll to top